{
  "id": "clinical#screening_cues_c9b33870",
  "content": "to psychomotor retardation in a depressive episode; agitation or impulsivity in secondary\ncatatonia syndrome is similar to increased activity and impulsive reckless behaviour in a manic\nepisode). In secondary catatonia syndrome, these symptoms occur in conjunction with other\ncatatonic symptoms (e.g. abnormal psychomotor activity such as mannerisms, waxy flexibility or\nposturing), which are not characteristic of secondary mood syndrome.\nBoundary with mood symptoms caused by substances or medications, including\nwithdrawal effects\nWhen establishing a diagnosis of secondary mood syndrome, it is important to rule out the\npossibility that a medication or substance is causing the mood symptoms instead of –or in\naddition to – an underlying medical condition. This involves first considering whether any of\nthe medications being used to treat the medical condition are known to cause depressive or\nmanic symptoms (e.g. steroids or alpha-interferon) at the dose and duration at which it has been\nadministered. Second, a temporal relationship between the medication use and the onset of the\nmood symptoms should be established (i.e. the mood symptoms began after administration of the\nmedication and/or remitted once the medication was discontinued). The same reasoning applies",
  "metadata": {
    "source": "WHO ICD-11",
    "url": "https://icd.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "relationships",
      "communication_tips",
      "screening_cues",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues to psychomotor retardation in a depressive episode; agitation or impulsivity in secondary\ncatatonia syndrome is similar to increased activity and impulsive reckless behaviour in a manic\nepisode). In secondary catatonia syndrome, these symptoms occur in conjunction with other\ncatatonic symptoms (e.g. abnormal psychomotor activity such as mannerisms, waxy flexibility or\nposturing), which are not characteristic of secondary mood syndrome.\nBoundary with mood symptoms caused by substances or medications, including\nwithdrawal effects\nWhen establishing a diagnosis of secondary mood syndrome, it is important to rule out the\npossibility that a medication or substance is causing the mood symptoms instead of –or in\naddition to – an underlying medical condition. This involves first considering whether any of\nthe medications being used to treat the medical condition are known to cause depressive or\nmanic symptoms (e.g. steroids or alpha-interferon) at the dose and duration at which it has been\nadministered. Second, a temporal relationship between the medication use and the onset of the\nmood symptoms should be established (i.e. the mood symptoms began after administration of the\nmedication and/or remitted once the medication was discontinued). The same reasoning applies To psychomotor retardation in a depressive episode; agitation or impulsivity in secondary\ncatatonia syndrome is similar to increased activity and impulsive reckless behaviour in a manic\nepisode). in secondary catatonia s..."
}